US Pet Spending Projected at $165 Billion in 2026 as Owners Test Human Longevity Treatments on Dogs
Pet owners replicate human longevity regimens on dogs amid rising expenditures. Data show $165 billion projected spend by 2026 with limited veterinary oversight. The move reflects direct transfer of unproven interventions across species boundaries.
Owners cite human longevity protocols as the model, extending interventions to companion animals without completed clinical data on canine outcomes. The Bloomberg report records this shift occurring alongside broader consumer health trends rather than through regulatory approval pathways. Veterinarians have documented requests for off-label use while noting absence of peer-reviewed safety thresholds for these compounds in non-human subjects.
AVMA: At least three state veterinary boards issue formal cautions on rapamycin use in pets by Q4 2027
Sources (2)
- [1]Primary Source(https://www.bloomberg.com/news/videos/2026-08-16/longevity-boom-reaches-america-s-pets-video)
- [2]Supporting Source(https://www.americanpetproducts.org)